Bitrobius Genetics


Developing a plasmid-based gene-therapy platform that delivers self-replicating DNA to target organs, enabling intercellular spread of corrective genes. The organisation focuses on engineering plasmid constructs that express therapeutic proteins, replicate within cells, and translocate between adjacent cells, and is adapting the approach for mitochondrial gene delivery. The site states an emphasis on developing therapies for genetic diseases lacking effective treatments and on enabling more scalable manufacture compared with current viral-vector approaches.

Industries

Biotechnology
Health Care
Medical
Biotechnology Research

Nr. of Employees

small (1-50)

Bitrobius Genetics

Macclesfield, England, United Kingdom


Products

Plasmid-based intercellular gene-delivery platform

A platform using plasmid DNA that replicates in host cells, expresses therapeutic proteins, and translocates to adjacent cells to spread corrective genetic material across affected tissues; being adapted for mitochondrial delivery.

Gentrafix

Groundbreaking plasmid technology that delivers therapeutic proteins directly to target cells, offering a revolutionary approach to curing genetic diseases.


Services

Engagements with funders and research partners to support development and translation of plasmid-based gene therapies.

Expertise Areas

  • Plasmid engineering
  • Gene therapy platform development
  • Mitochondrial gene therapy
  • Preclinical therapeutic development
  • Show More (2)

Key Technologies

  • Plasmid-based gene delivery
  • Intercellular DNA translocation
  • Mitochondrial DNA translocation
  • Therapeutic gene expression from plasmids
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.